GETECCU Update. Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients...

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU Lucía Madero y Violeta Moreno Hospital General Universitario Dr. Balmis, Alicante